Rakuten Aspyrian closes $284 Million Series C Financing for late-stage oncology pipeline

Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoi...

December 26, 2018 | Wednesday | News
Mundipharma applies for marketing Remimazolam in Japan

Mundipharma has submitted an application to the Japanese Pharmaceuticals and Medical Devices Agency to market Remimazola...

December 21, 2018 | Friday | News
Roivant Sciences, Daiichi Sankyo enter into broad pipeline partnership

Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, D...

December 20, 2018 | Thursday | News
Ajinomoto and XL-protein unite to develop therapeutic compounds

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in&nb...

December 19, 2018 | Wednesday | News
Fuji Pharma Invests in Alvotech for $50M

Biopharmaceutical company Alvotech has announced that Japan-based Fuji Pharma has acquired a 4.2% stake in the business ...

December 19, 2018 | Wednesday | News
Study shows Stelara works superbly in Crohn’s disease

Following the announcement of positive results from Janssen’s Phase III open-label long-term extension study, whic...

December 18, 2018 | Tuesday | News
AIVITA Biomedical to sell skincare line in Japan

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, has announced that the Com...

December 18, 2018 | Tuesday | News
Eisai signs pact with Eurofarma for anti-Obesity agent

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity a...

December 17, 2018 | Monday | News
Luye Pharma submits its Parkinson’s drug for clinical trial approval

Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003...

December 13, 2018 | Thursday | News
GHIT Fund to invest $4.6M for new projects on drug development

The Global Health Innovative Technology (GHIT) Fund has announced a total of 520 million yen ($4.6 million) to support f...

December 13, 2018 | Thursday | News
Eisai, Takeda and GARDP sign pact to develop novel antibiotics

The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. and Takeda Pharmaceutical Company Li...

December 13, 2018 | Thursday | News
HitGen, Mitsubishi Tanabe Pharma ink deal to foster drug discovery

China-based HitGen announced that the company has entered into a drug discovery research collaboration with Mitsubishi T...

December 11, 2018 | Tuesday | News
Mundipharma to distribute Norspan in Japan

Mundipharma and Hisamitsu Pharmaceutical have agreed that Hisamitsu Pharmaceutical will end distribution of dermally abs...

December 11, 2018 | Tuesday | News
Cabinet approves MoU between India, Japan for Healthcare and Wellness

The Union Cabinet chaired by Prime Minister Narendra Modi today has given its ex-post facto approval on the Memoran...

December 7, 2018 | Friday | News
Daiichi Sankyo shows updated Phase 1 Data for U3-1402 in cancer patient

Daiichi Sankyo Company, Limited announced that updated efficacy and safety results from the ongoing phase 1/2 study...

December 6, 2018 | Thursday | News
AGC enters agreement to acquire Malgrat Pharma

AGC Inc., a world-leading manufacturer of glass, chemicals and high-tech materials, has announced that it has entered in...

December 5, 2018 | Wednesday | News
VSee Telehealth launches in Japan

VSee, the telehealth company behind NASA International Space Station, Walgreens, MDLIVE, DaVita, Trinity, Ascension and ...

December 5, 2018 | Wednesday | News
Researchers develop platelets in lab

Researchers have developed a way to grow human platelets in the laboratory from stem cells derived from fat tissue. Thes...

November 30, 2018 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls